Kaiser completes national EMR rollout

If approved, doravirine/islatravir would be the first two-drug HIV treatment regimen without an integrase inhibitor, according to the Merck news release.

Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the "Conversations with Perry and Friends" podcast. In this episode, Cohen speaks with Saar Mahna, J.D., MBA, CEO and founder of Banjo Health, an artificial intelligence company focused on prior authorization.

But 25 low- and middle-income countries have responded with plans for increased allocation of HIV funds, says the UNAIDS executive director. "...countries, governments and civil society are not lying down and waiting to die..."

Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.

All 10 participants in this trial showed improvements in hearing within the first month of receiving the gene therapy, which delivered healthy copies of the OTOF gene.

The eavesdropping artificial intelligence saves physicians time and means more eye contact during patient visits.